Reseach of amino acid in the newborn

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006106

Enrollment

Unknown

Registered

2015-03-18

Start date

2015-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malnutrition

Interventions

standard dose group:amino acide with standard dose

satisfied dose group:amino acide with satisfied dose

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1h newborn after birth

Exclusion criteria

Exclusion criteria: 1. Severe hepatic-renal dysfunction; 2. Major congenital abnormalities considered to be life threatening or anomalies (such as cyanotic congenital heart disease, gastrointestinal tract anomalies); 3. Congenital inherited metabolic diseases; 4. Written informed consent was not obtained from the parents.

Design outcomes

Primary

Measure	Time frame
body weight;height;head circumference;hospital stay;nitrogen balance;duration of parenteral nutrition;	—

Secondary

Measure	Time frame
growing development of 1 year;evaluation of nervous system;diseases of organ;	—

Countries

China

Contacts

Public ContactChen Xiaoqing

chenxq2002@foxmail.com+86 13951676702

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026